|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net earnings (loss) | |||||
| Adjustments to reconcile net earnings (loss) to operating cash flow: | |||||
| Equity method earnings, net of taxes | |||||
| Impairment | |||||
| Gain on pension settlement | |||||
| Depreciation | |||||
| Depreciation and amortization | |||||
| (Earnings) loss from equity method investments, net of distributions | |||||
| (Gain) loss on sales of assets | |||||
| Stock-based compensation | |||||
| Deferred taxes | |||||
| Changes in assets and liabilities | |||||
| Other | |||||
| Operating cash flow | |||||
| INVESTING CASH FLOW | |||||
| Gain on the fair value of the forward sale contract of NuScale shares | |||||
| Purchases of marketable securities | |||||
| Proceeds from sales and maturities of marketable securities | |||||
| Capital expenditures | |||||
| NuScale cash deconsolidated | |||||
| Proceeds from sales of assets (net of cash divested) | |||||
| Investments in partnerships and joint ventures | |||||
| Return of capital from partnerships and joint ventures | |||||
| Other | |||||
| Investing cash flow | |||||
| FINANCING CASH FLOW | |||||
| Repurchase of common stock | |||||
| Proceeds from issuance of 2029 Notes, net of issuance costs | |||||
| Capped call transactions related to 2029 Notes | |||||
| Purchases and retirement of debt | |||||
| Proceeds from NuScale de-SPAC transaction | |||||
| Proceeds from NuScale share issuance (net of issuance fees) | |||||
| Proceeds from issuance of CPS | |||||
| Dividends paid on CPS | |||||
| Make-whole payment on conversion of CPS | |||||
| Distributions paid to NCI | |||||
| Capital contributions by NCI | |||||
| Other | |||||
| Financing cash flow | |||||
| Effect of exchange rate changes on cash | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...